SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?

Wallin, A; Alladi, S; Black, SE; Chen, C; Greenberg, SM; Gustafson, D; Isaacs, JD; Jokinen, H; Kalaria, R; Mok, V; et al. Wallin, A; Alladi, S; Black, SE; Chen, C; Greenberg, SM; Gustafson, D; Isaacs, JD; Jokinen, H; Kalaria, R; Mok, V; Pantoni, L; Pasquier, F; Roman, GC; Rosenberg, GA; Schmidt, R; Smith, EE; Hainsworth, AH (2022) What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders? Cereb Circ Cogn Behav, 3. p. 100044. ISSN 2666-2450 https://doi.org/10.1016/j.cccb.2022.100044
SGUL Authors: Hainsworth, Atticus Henry Isaacs, Jeremy

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (352kB) | Preview

Abstract

•Controversial registration of aducanumab for Alzheimer's Disease •Aducanumab is the subject of post-licensing observational studies aiming to follow the effects of the drug •Given the high prevalence of cerebrovascular pathology it is important that these studies do not ignore vascular cognitive disorders •The studies may give detailed phenotyping data that may lead to knowledge of targets for treatments of patients with vascular cognitive disorders.

Item Type: Article
Additional Information: © 2022 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Cereb Circ Cogn Behav
ISSN: 2666-2450
Language: eng
Dates:
DateEvent
20 February 2022Published
11 February 2022Published Online
6 February 2022Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
MR/T033371/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
PubMed ID: 36324416
Web of Science ID: WOS:001056889700016
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116097
Publisher's version: https://doi.org/10.1016/j.cccb.2022.100044

Actions (login required)

Edit Item Edit Item